SNHG5 promotes tumor cell proliferation, survival, and drug resistance by sponging miRNAs to enhance gene expression (Damas et al., 2016; Li et al., 2019b; Li et al., 2018; Zhang et al., 2019). The gene discussed is SNHG5; the disease is neoplasm.